ArticleFrontiers in immunology2026

Targeting NOP14 remodels the tumor immune microenvironment and enhances the antitumor efficacy of PD-1 blockade in DLBCL.

Lu Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.